Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus - an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (replace)-2 trial

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Gurm, H. S.
  • Sarembock, I. J.
  • Kereiakes, D. J.
  • Young, J. J.
  • Harrington, R. A.
  • Kleiman, N.
  • Feit, F.
  • Wolski, K.
  • Bittl, J. A.
  • Wilcox, R.
  • Topol, Eric
  • Lincoff, A. M.
  • Investigators, Replace-

publication date

  • 2005

journal

  • Journal of the American College of Cardiology  Journal

subject areas

  • Aged
  • Angioplasty, Balloon, Coronary
  • Anticoagulants
  • Coronary Artery Disease
  • Diabetes Mellitus, Type 2
  • Double-Blind Method
  • Female
  • Heparin
  • Hirudins
  • Humans
  • Male
  • Middle Aged
  • Peptide Fragments
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Recombinant Proteins
  • Treatment Outcome
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0735-1097

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2005.02.074

PubMed ID

  • 15963389
scroll to property group menus

Additional Document Info

start page

  • 1932

end page

  • 1938

volume

  • 45

issue

  • 12

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support